Your present location:HOMENewsCompany news > Qilu Pharmaceutical (Inner Mongolia) Passes U.S. FDA Inspection
News Detail

Qilu Pharmaceutical (Inner Mongolia) Passes U.S. FDA Inspection

Number of visits: Date:4/14/2018 05:58 PM
The USFDA has completed the GMP compliance inspection of Qilu Pharmaceutical (Inner Mongolia), a subsidiary of Qilu Pharma Group. The inspection commenced on April 9, 2018, and was completed on April 12, 2018. All quality systems were evaluated in the inspection, and the facility received a successful response with ZERO FDA 483 observations.The good inspection results speak to our commitment to high standards of quality and excellence.It is the first FDA inspection for Inner Mongolia facilities, which represents an important milestone for the company to enter the US market.
TypeInfo: Company news Keywords for the information: